Third Harmonic Bio (THRD) Stock Highlights

10.84 | -0.37%

2024-12-21 05:12:11

Third Harmonic Bio Inc is a clinical-stage company developing a novel oral approach to the treatment of severe allergy and inflammation. The companys lead product candidate, THB001, is a highly selective, oral small-molecule inhibitor of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival.

Statistics

Range Today

10.4 11.19

Volume Today 426K

Range 1 Year

8.07 16.94

Volume 1 Year 37.44M

Range 3 Year

3.75 24.59

Volume 3 Year 91.5M

Range 10 Year

3.75 24.59

Volume 10 Year 91.5M

Highlights

Market Capitalization 616.46M (small)

Floating Shares 8.41M

Current Price 10.84

Price To Earnings -16

Price To Book 2.24

Earnings Per Share -0.88

Payout Ratio 0%

Performance

Latest -0.37%

1 Month -11.65%

3 Months -25.7%

6 Months -10.86%

1 Year +0.65%

3 Years -36.24%

5 Years -36.24%

10 Years -36.24%

Benchmarks

Market Capitalization

0 / 368

Gross Profits

0 / 278

Total Revenue

0 / 300

Total Rank

0 / 368

Free Cashflow

0 / 352

Performance 5 years

0 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.